Loading the session
Loading the session
Loading instrument
$9.42
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: −11.1% (SPY −1.6%, XLV +13.5%). 3 months: −24.9% (SPY −0.4%, XLV +15.5%). 1 year: +10.0% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MGTX, SPY and XLV · as of 4 Nov 2026
6.4M shares were sold short at the 15 Oct 2026 settlement, 6.7% of the 96.0M shares outstanding; covering them would take 6.5 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 4 Nov 2026 close of $9.42 was 17.4% below its 50-day average ($11.40) and 8.9% below its 200-day average ($10.34). It has closed below the 200-day for 17 sessions, since 13 Oct 2026. The 50-day average crossed above the 200-day on 17 Apr 2026, 139 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Closed at $9.42 on 4 Nov 2026: 38.6% below the 52-week high of $15.35 (7 Jul 2026) and 42.3% above the low of $6.62 (5 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
March 13, 2025
+28.71%December 21, 2023
+32.59%October 30, 2023
+20.27%